The University of Buffalo, in the US, has been awarded a $600,000 grant to run a study into whether the injectable diabetes medication Victoza can improve blood glucose levels for young people with type 1 diabetes.
The study, which is being funded by the American Diabetes Association will recruit 45 patients with type 1 diabetes between the ages of 15 and 30 years old. The participants will be studied over a period of 3 years.
Victoza, also known as liraglutide, is an injectable medication that is currently prescribed to people with type 2 diabetes that meet certain criteria. Liraglutide works by increasing secretion of insulin but also by decreasing the secretion of glucagon. It is the suppression of glucagon that could be useful in people with type 1 diabetes and could help to reduce high blood sugar level peaks.
Younger people with type 1 diabetes often have difficulty controlling blood sugar levels and it can be a struggle to prevent blood sugars from fluctuating wildly. Initial studies have shown promise that liraglutide could help to improve manageability of blood sugar levels by reducing HbA1c levels and reduce instances of hypoglycemia.
US to trial Victoza medication in teens with type 1 diabetes
Tue, 28 Feb 2012
Your comments may be moderated. Please report any spam, illegal, offensive or libellous posts.
Also related to this storyVictoza (liraglutide)
Type 1 diabetes
Blood glucose management
Type 1 diabetes forum
Type 2 Diabetes
Type 1 Diabetes
Low Carb Diet
Diabetes in India
Insulin production may last for over 30 years in type 1 diabetes
Diabetes expert claims that type 1 diabetes is curable
Teenagers with type 1 diabetes have changed brains
Bold new avenue for type 1 diabetes research
Stem cell research could help reverse type 1 diabetes, says study
Girl raises funds for type 1 diabetes research
New research programme into type 1 diabetes
New research on cure for type 1 diabetes
Nasal spray helps combat type 1 diabetes
People should be more aware of hypos for type 1 diabetes
Victoza shown to also benefit type 1 diabetes
Diamyd type 1 diabetes vaccine stalls in European trials
Protein may predict development of type 1 diabetes, according to study
New type 1 diabetes trials approved for the Sanford Project
Information resource launched for adults with type 1 diabetes
Type 1 diabetes frequently diagnosed late after onset of dangerous DKA
Preadolescent children with type 1 diabetes more prone to heart disease, says report
Type 1 diabetes in children linked with viral infection
Glucagon could become insulin replacement for type 1 diabetes treatment
Link between depression and type 1 diabetes reported
Study looks at type 2 diabetes drug that could help those with type 1 diabetes